Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06228937

Gut Microbiota in Patients With Limb Lymphedema and Recurrent Lymphangitis

Typing of Gut Microbiota in Patients With Limb Lymphedema and Recurrent Lymphangitis, a Prospective Observational Study

Status
Recruiting
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

Lymphedema is a chronic and progressive disease of the lymphatic vessels which affects about 300 million people worldwide. Patients may experience recurrent soft tissue infection of the limb affected by lymphedema, in terms of erysipelas, lymphangitis or cellulitis. No previous study has ever investigated the possible role of the gut microbiota in the genesis of acute infectious/inflammatory episodes in these patients. Our hypothesis is that lymphedema patients with recurrent soft tissue infections are characterized by pro-inflammatory changes in the microbiota.

Conditions

Interventions

TypeNameDescription
OTHERanalysis of a sample of stooltyping of the gut microbiota from a stool sample

Timeline

Start date
2024-02-22
Primary completion
2027-10-30
Completion
2028-10-30
First posted
2024-01-29
Last updated
2024-02-28

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06228937. Inclusion in this directory is not an endorsement.

Gut Microbiota in Patients With Limb Lymphedema and Recurrent Lymphangitis (NCT06228937) · Clinical Trials Directory